Clinical Trial Update: Capnography During Percutaneous Transhepatic Cholangiodrainage (PTCD) (HepaBreath) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update on HepaBreath capnography during percutaneous transhepatic cholangiodrainage (PTCD) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Apnea
• Hypoxemia

Snippet

Sponsor: Technical University of Munich | Conditions: Apnea, Hypoxemia | Phase 3 | Status: COMPLETED